The Blue Jays and the Toronto press are fueding with each other

Getty Images
24 Comments

The Blue Jays are poised to make the playoffs for the second year in a row and are playing a critical series with the Orioles, the outcome of which will likely determine who gets to play at home for that one-and-done game next week. Big stakes! Must keep focused!

Or, alternatively, maybe it’s time to have a silly, juvenile feud with the press. Here’s Steve Buffery of the Toronto Sun, asking why the Jays are doing stuff like this while fighting for the playoffs:

Why, for example, would the leaders on the team allow someone to put up on a wall photos of two Toronto sports writers with an ‘X’ scratched on their face and the a message written on top reading, ‘Do not grant them interviews’ (or words to that effect)? . . . Things like: Someone cranking up the music just when the media arrives to conduct pre-game interviews.

Not that the Jays have been treated wonderfully by the press themselves:

There was an incident the other night when a couple of journalists tried to corral struggling closer Roberto Osuna for an interview, but he kept blowing them off. Finally, one reporter followed him right into a private part of the clubhouse and told him off.

That’s . . . not what you’re supposed to do.

Still, there is zero point to get into silly feuds with the media. If they overstep their bounds, there are a TON of Jays officials and, I suspect, newspaper editors, who will quickly and eagerly discipline the reporter. You don’t have to make wanted posters and act like children. Partially because it’s just a bad look. But also, because it leads to news stories about it like the one in the Toronto Sun.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.